Clinical Trials on 体细胞突变乳腺癌 (BRCA1) in Korea, Republic of
总计844个结果
-
Kyung Hee University Hospital at GangdongKorea Health Industry Development Institute主动,不招人
-
Samsung Medical Center完全的
-
Seoul National University HospitalNational Evidence-Based Healthcare Collaborating Agency主动,不招人
-
Seoul National University Hospital主动,不招人
-
National Cancer Center, Korea未知
-
National Cancer Center, Korea未知
-
Yonsei University完全的
-
Asan Medical CenterKyowa Kirin Co., Ltd.终止
-
Jungsil RoGlaxoSmithKline; HK inno.N Corporation完全的
-
Samsung Medical CenterKorean Breast Cancer Study Group招聘中
-
Samsung Medical CenterMinistry of Health, Republic of Korea完全的
-
Hoffmann-La Roche终止
-
National Cancer Center, KoreaAsan Medical Center; Korea University Anam Hospital; Seoul National University完全的
-
Samyang Biopharmaceuticals Corporation招聘中
-
National Cancer Center, Korea完全的
-
Boryung Pharmaceutical Co., Ltd完全的
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Severance Hospital未知
-
National Cancer Center, Korea完全的
-
MacroGenicsNational Cancer Institute (NCI); Green Cross Corporation完全的
-
Samsung Medical Center完全的
-
Seoul National University Hospital完全的
-
Imperial College London完全的
-
VA Office of Research and Development招聘中转移性去势抵抗性前列腺癌 | BARD1、BRCA1、BRCA2、BRIP1、CHEK1、芳珂、PALB2 | RAD51B、RAD51C、RAD51D 或 RAD54L 突变美国
-
Samsung Medical Center主动,不招人EGFR T790M 突变的非小细胞肺癌 | 有脑和/或软脑膜转移 | 失败的酪氨酸激酶抑制剂大韩民国
-
EnhancedBio USA Inc.Zenopharm招聘中